fbpx


The headquarters of German immunotherapy company BioNTech stands on April 22, 2020 in Mainz, Germany.

Thomas Lohnes | Getty Images

German biotech firm BioNTech and U.S. drugmaker Pfizer on Monday reported additional data from their experimental coronavirus vaccine that showed the vaccine was safe and induced an immune response in patients.

The results were disclosed from a trial in Germany testing 60 healthy volunteers, and come after the companies earlier this month reported data from a corresponding early-stage trial in the United States.



Source link

Write A Comment